Notes - Significant Accounting Policies For Preparation Of Semi-Annual Consolidated Financial Statements

Carna Biosciences, Inc. - Filing #7727404

Concept As at
2017-12-31
2017-01-01 to
2017-12-31
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Disclosure of scope of consolidation
Number of consolidated subsidiaries and names of major consolidated subsidiaries

  すべての子会社を連結しております。

連結子会社の数

2社

連結子会社の名称

CarnaBio USA, Inc.

株式会社ProbeX

 

Number of consolidated subsidiaries
2 xbrli:pure
Disclosure about fiscal years, etc. of consolidated subsidiaries

2 連結子会社の事業年度等に関する事項

  連結子会社の決算日は、連結決算日と一致しております。

 

Talk to a Data Expert

Have a question? We'll get back to you promptly.